Thrombin and other coagulation proteases mediate a variety of eff ects independently of thrombosis through specifi c protease-activated receptors (PARs), stimulation of which can amplify infl ammation initiated by several diverse stimuli ( 1 ). Although the proinfl ammatory consequences of PAR stimulation have been implicated in several diseases ( 2 -4 ), it has yet to be established whether thrombin or PAR activation provides a unique stimulus responsible for a nonthrombotic manifestation of infl ammation.
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Thrombin and other coagulation proteases mediate a variety of eff ects independently of thrombosis through specifi c protease-activated receptors (PARs), stimulation of which can amplify infl ammation initiated by several diverse stimuli ( 1 ). Although the proinfl ammatory consequences of PAR stimulation have been implicated in several diseases ( 2 -4 ) , it has yet to be established whether thrombin or PAR activation provides a unique stimulus responsible for a nonthrombotic manifestation of infl ammation.
Working in a model of acute humoral xenograft rejection (mouse heart into rat), we previously reported that inhibiting thrombin generation or inhibiting thrombin itself inside the graft (using organs from transgenic [Tg] mice expressing endothelial cell [EC]-tethered anticoagulants) completely inhibited humoral rejection so that hearts were rejected by infi ltrating T lymphocytes ( 5 ) . These fi ndings were surprising because the rejected hearts had signifi cant Ig and C deposition on graft ECs. Inhibiting thrombosis by depleting fi brinogen from the recipients (using a snake venom protein, ANCROD) failed to achieve the same degree of survival, and under these conditions, infi ltrating NK cells and macrophages (M ⌽ s), rather than T cells, were observed in rejected grafts ( 6 ) . From these studies we hypothesized that thrombin was providing a stimulus in the humoral rejection process that was necessary for the infi ltration of NK cells and M ⌽ s. We have tested this hypothesis and confi rmed our conclusions in a second model of thioglycollateinduced M ⌽ recruitment into the peritoneum.
RESULTS AND DISCUSSION Donor monocyte chemoattractant protein (MCP)-1 is required for NK cell and M ⌽ recruitment
We hypothesized that infi ltration of NK cells and M ⌽ s into rejecting mouse hearts was due to the establishment of a chemokine gradient, most likely MCP-1, a CC chemokine known to be essential for NK cell and M ⌽ recruitment. ments confi rmed CCR2 expression by rat NK cells (as other species; reference 7 ) and showed that mouse MCP-1 acted as a chemoattractant for rat cells (not depicted).
Inhibition of PAR-1 activation inhibits donor MCP-1 production
Rejected hearts from Tg mice (CD31-Hir-Tg) expressing a tethered hirudin fusion protein (a direct specifi c inhibitor of thrombin) on activated ECs ( 5 ) showed minimal NK cell or M ⌽ infi ltration, except when rats were given an inhibitory anti-hirudin mAb ( Fig. 1, b and c ) . Rejection was associated with low plasma levels of both mouse and rat MCP-1 ( Fig. 1 a ) , suggesting that both were thrombin dependent. When measured on day 3 and normalized for zero using values from recipients of MCP-1 KOs, circulating mouse MCP-1 levels in ANCROD-treated recipients of WT hearts were > 10 times
We confi rmed that rejection of WT hearts was associated with elevated plasma levels of both recipient and donor MCP-1 ( Fig. 1 a ) . Hearts from MCP-1 KO mice were transplanted into ANCROD-treated rats. As previously reported, pre-transplant fi brinogen levels were depleted to 5% of the levels seen in control rats, and hearts rejected by ANCRODtreated rats contained no evidence of fi brin deposition ( 5 ) . Fibrinogen levels were maintained at 5 -8% control values to the time of rejection (0.23 ± 0.03 in ANCROD-treated rats vs. 2.78 ± 0.4 g/liter in controls; n = 3; P < 0.0001). MCP-1 KO hearts had a mean survival time (MST) of 5.5 ± 0.22 d (vs. 3.83 ± 0.31 d for WT plus ANCROD; n = 6; P = 0.004) and at rejection had fewer infi ltrating NK cells and M ⌽ s ( Fig. 1, b and c ) ( 6 ) , despite high rat MCP-1 levels ( Fig. 1 a ) . Thus, donor but not recipient MCP-1 was associated with infi ltration by rat infl ammatory cells and graft rejection. In vitro experi- 
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on direct PAR-1 activation on donor tissue, rather than being stimulated indirectly by the actions of rat cytokines generated in a thrombin-dependent way.
Donor PAR-1 activation enhances production of donor MCP-3 and MCP-5, but not recipient chemokines or cytokines There were fewer NK cells and M ⌽ s in PAR-1 KO or CD31-Hir-Tg hearts than in MCP-1 KO hearts, despite the fact that both made more MCP-1, suggesting that additional donor those seen in recipients of CD31-Hir-Tg hearts (37.9 ± 7.16 vs. 3.6 ± 1.9 pg/ml; n = 6; P = 0.01), indicating that > 90% of mouse MCP-1 generation was inhibited by the hirudin. Therefore, we hypothesized that hirudin, by inhibiting thrombin, prevented the generation of mouse MCP-1.
To test this hypothesis, WT hearts were transplanted into rats given ANCROD with highly selective antagonists (antAgs) to PAR-1, PAR-4, or both. Generation of mouse MCP-1 was inhibited only by the PAR-1 antAg to levels similar to those in animals transplanted with CD31-Hir-Tg hearts (compare Fig. 1, d and a ). The PAR-1 antAg also inhibited NK and M ⌽ infi ltration ( Fig. 1 c ) and prolonged survival (MST 5.83 ± 0.31 d; n = 6; P = 0.003 compared with ANCROD alone). Although the PAR-4 antAg prolonged survival (MST 5.17 ± 0.31 d; n = 6; P = 0.006 vs. WT plus ANCROD), rejection was accompanied by signifi cant NK cell and M ⌽ infi ltration ( Fig. 1 c ) . Both antAgs together had no additional impact compared with PAR-1 antAg alone (MST 6.33 ± 0.33 d; n = 6; P = NS). The selectivity of these antAgs was confi rmed in vitro (see Fig. 2 ). Donor MCP-1 production, recruitment of NK cells and M ⌽ s, and graft survival were not altered when rat recipients of CD31-Hir-Tg hearts were treated with PAR-1 or PAR-4 antAgs (not depicted).
PAR-1 activation promotes donor MCP-1 production
In contrast, when rats transplanted with hearts from CD31-Hir-Tg mice were given highly selective agonist (Ag) peptides for PAR-1, PAR-4, or PAR-2, the PAR-1 Ag promoted significant mouse MCP-1 generation ( Fig. 1 d ) , infiltration by NK cells and M ⌽ s ( Fig. 1 c ) , and accelerated rejection (MST 4 ± 0.26 d vs. 6.67 ± 0.21 d for PAR-4 Ag, P = 0.0006; 6.33 ± 0.21 d for PAR-2 Ag, P = 0.0006; or 6.67 ± 0.33 d for rats receiving no Ag, P = 0.0006; n = 6 each group). These data show that signaling through PAR-1 alone was suffi cient to promote donor MCP-1 production and infi ltration by NK cells and M ⌽ s. To show that MCP-1 was responsible for recruitment, recipients of CD31-Hir-Tg hearts were given an inhibitory anti -MCP-1 mAb with the PAR-1 Ag. Compared with controls, these hearts had few NK cells or M ⌽ s ( Fig. 1 c ) and survived longer (MST 5.33 ± 0.21 d vs. 3.83 ± 0.17 d; n = 6; P = 0.001).
Production of donor MCP-1 is dependent on activation of donor PAR-1
In vitro experiments with purifi ed mouse heart microvascular ECs showed that MCP-1 production was mediated predominantly through PAR-1 ( Fig. 2, a -d ) . In vivo, hearts from PAR-1 KO mice were transplanted into ANCROD-treated rats. Compared with defi brinogenated rats receiving WT hearts with PAR-1 antAg, levels of mouse MCP-1 were as low (compare Figs. 2 e and 1 d ), hearts were as poorly infi ltrated by either NK cells or M ⌽ s (compare Figs. 2 f and 1 c ), and survival was comparable (MST 5.17 ± 0.31 d; n = 6; P = NS), and this was signifi cantly longer than that in ANCROD-treated animals given WT hearts without PAR-1 antAg (P = 0.02). Therefore, generation of the donor MCP-1 was dependent chemokines may play a role in recruiting mononuclear cells. Consistent with this, mouse MCP-3 and MCP-5 were found circulating at lower levels in recipients of PAR-1 KO and CD31-Tg hearts than in recipients of WT hearts ( Fig. 3, a and b ) . In the latter, levels were signifi cantly inhibited by the PAR-1 antAg, whereas conversely, after CD31-Hir-Tg hearts were transplanted, levels were increased by the PAR-1 Ag ( Fig. 3, a  and b ) . Two other observations appear signifi cant. First, consistent with a previous report ( 8 ) , mouse MCP-3 was found at negligible levels after transplantation of MCP-1 KO hearts and after rats were given the anti -MCP-1 antibody ( Fig. 3 a ) , suggesting that MCP-3 production is MCP-1 dependent. Second, donor MCP-5 levels were signifi cantly inhibited and enhanced by the PAR-4 antAg or Ag, respectively ( Fig. 3 b ) .
In contrast, rat MCP-1 was found at comparable levels in defi brinogenated recipients of WT and PAR-1 KO hearts (compare Figs. 2 e and 1 a ), as were rat IFN-␥ , TNF-␣ , and IL-6 ( Fig. 3, c -e ) , indicating that donor PAR-1 was not involved. The concentrations of all four were also high in rats receiving MCP-1 KO or WT hearts in the context of an anti -MCP-1 antibody ( Figs. 1 a and 3 , c -e , and not depicted for rat MCP-1), indicating that levels did not correlate with the degree of mononuclear cell infi ltration.
Nevertheless, rat MCP-1 (not depicted), IFN-␥ , IL-6, and to a lesser extent TNF-␣ were signifi cantly suppressed by the PAR-1 antAg when administered to ANCROD-treated rats and enhanced by the PAR-1 but not PAR-4 Ag when administered to rats receiving CD31-Hir-Tg hearts ( Fig. 3, c -e ) . Both rat NK cells and M ⌽ s expressed PAR-1 and PAR-4 by fl ow cytometry (not depicted), so these data are most consistent with the hypothesis that thrombin, generated in the graft, amplifi es chemokine and cytokine production by rat mononuclear cells via PAR-1 but is insuffi cient, by itself, to promote infi ltration in the absence of mouse MCP-1 generation.
PAR-1 is important for MCP-1 -dependent recruitment in a nontransplantation model
M ⌽ recruitment into the peritoneum after instillation of thioglycollate is known to be MCP-1 dependent ( 9 ), and we confi rmed this using MCP-1 KO mice ( Fig. 4, a and b ) . Using PAR-1 KO mice we demonstrated that levels of MCP-1, MCP-3, and MCP-5 ( Fig. 4, c -e ) and M ⌽ recruitment ( Fig. 4 , b and c ) were dependent on PAR-1. WT mice injected with PAR-1 antAg and CD31-Hir-Tg mice had signifi cantly reduced levels of circulating MCP-1, MCP-3, and MCP-5 and accordingly showed signifi cantly reduced M ⌽ recruitment ( Fig. 4, a -e ) . Finally, injection of PAR-1 Ag into the Tg mice signifi cantly enhanced levels of circulating chemokines and M ⌽ recruitment ( Fig. 4, b -e ) . No mice received ANCROD in these experiments. Therefore, PAR-1 is required to generate MCP-1, MCP-3, and MCP-5 for infl ammatory cell recruitment.
The importance of MCP-1 for mononuclear cell recruitment has been shown in various animal models of disease ( 9 -13 ). Our results confi rm that peritoneal M ⌽ recruitment after thioglycollate is signifi cantly reduced in MCP-1 KO mice, and we demonstrate for the fi rst time the importance black, PAR-1 KO. Statistics: (a) MCP-3: compared with WT into defi brinogenated rats: *, P ≤ 0.01; § , P = NS; CD31-Hir-Tg into normal rats: † , P < 0.05; #, P = NS; isotype control: ¶ , P < 0.05; (b) MCP-5: compared with WT into defi brinogenated rats: *, P < 0.02; § , P = NS; CD31-Hir-Tg into normal rats: † , P < 0.05; #, P = NS; isotype control: ¶ , P = NS; (c) IFN-␥ : compared with WT into defi brinogenated rats: *, P ≤ 0.04; § , P = NS; CD31-Hir-Tg into normal rats: † , P < 0.02; #, P = NS; isotype control: ¶ , P = NS; (d) TNF-␣ : compared with WT into defi brinogenated rats: *, P ≤ 0.04; § , P = NS; CD31-Hir-Tg into unmanipulated rats: † , P = 0.002; #, P = NS; isotype control: ¶ , P = NS; (e) IL-6: compared with WT into defi brinogenated rats: *, P ≤ 0.04; § , P = NS; CD31-Hir-Tg into unmanipulated rats:
† , P = 0.002; #, P = NS; isotype control: ¶ , P = NS.
BRIEF DEFINITIVE REPORT
into unmanipulated rats, showed that PAR-1 activation on donor cells was necessary to generate suffi cient quantities of donor MCP-1 to promote leukocyte infi ltration. Similarly, MCP-1 generation and M ⌽ recruitment into the infl amed peritoneum after thioglycollate were PAR-1 dependent. Although this contrasts with fi ndings from a previous study in PAR-1 KO mice, which nevertheless reported thrombin-dependent M ⌽ recruitment after thioglycollate ( 14 ) , the fact that our distinct experimental approaches gave the same results of this chemokine for NK cell and M ⌽ recruitment during acute humoral rejection. By performing the transplant study in a xenogeneic model, it was possible to diff erentiate between MCP-1 made by donor tissue from that made by recipient. Only the former was associated with infi ltration into rejecting hearts.
Results from complimentary but distinct experimental approaches, using either WT or PAR-1 KO hearts transplanted into defi binogenated rats or CD31-Hir-Tg hearts transplanted Thrombin generation during systemic infl ammation is highly dependent on the procoagulant changes induced on endothelium ( 26 ) . Why mammals have evolved or maintained, as an integral part of EC activation, the switch from an anticoagulant to a procoagulant phenotype is interesting because if it results in intravascular thrombosis it can pose a direct threat to the survival of the individual, as often occurs during acute severe sepsis. The conventional explanation is that generating intravascular fi brin clots allows an organism to isolate certain types of infection ( 27 ) thereby limiting spread, a concept supported by a recent analysis showing the importance of plasminogen activators as pathogenicity factors for some types of bacterial infection ( 28 ) . Our data support an additional and complimentary explanation that there may be other advantages to the organism, based on thrombin-mediated signaling through PAR on vascular cells, that mediate eff ective production of chemokines such as MCP-1, resulting in the effi cient recruitment of leukocytes to clear or contain a localized source of infl ammation.
MATERIALS AND METHODS

Animals.
Male inbred Lewis rats (200 g) were from Harlan Olac. Donor hearts were from 25 -30-g WT, CD31-Hir-Tg ( 26 ), MCP-1-KO (reared by V. Perry, University of Southampton, Southampton, England, UK) ( 9 ), or PAR-1 KO mice ( 29 ) . Tg organs were from heterozygous and KO were from homozygous mice, backcrossed onto WT for > 10 generations. All animal procedures were approved by UK Home Offi ce. Cell culture. Mouse microvascular ECs were purifi ed and passaged as described previously ( 26 ) and used at passages 1 -3.
Cardiac transplantation. Heterotopic heart transplantation was performed as described previously ( 5 ) . PAR Ags (8 picomoles/g twice daily), PAR antAgs (10 μ g/g once daily [o.d.]), and ANCROD (0.08 U/g o.d. beginning pretransplantation) ( 6 ) were administered i.v. Anti -MCP-1 antibody (400 μ g pretransplant and 200 μ g o.d. thereafter) or control Armenian hamster IgG (eBioscience) was administered i.p. Graft rejection was defi ned as loss of regular palpable contractions on daily palpation. Graft MSTs are expressed as days ± SEM, and statistical signifi cance was determined using a log-rank test.
Thioglycollate-induced peritonitis. This was performed as by Lu et al. ( 9 ) . Mice received 1 ml sterile 4% thioglycollate broth (Sigma-Aldrich) or control saline i.p. Cells were harvested by peritoneal lavage with 3 ml of icecold HBSS and washed and resuspended in 1.2 ml PBS for fl ow cytometric analysis with a rat Cy5-labeled anti-CD11b and FITC-labeled anti-Ly6G (both from Abcam) or manual counting with a hemocytometer.
Immunohistology. Sections were prepared exactly as described previously ( 5 ) . The following antibodies were used: sheep anti-hirudin (Enzyme Research), rat anti -mouse CD31, FITC-conjugated goat anti -rat CD3, mouse anti -rat IgG (BD Biosciences), mouse anti -rat IgM, mouse anti -human ␣ -smooth muscle actin (Sigma-Aldrich), goat anti -rat C3, goat anti -rat IgG1, goat anti -mouse IgG3 (all from Autogen Bioclear), FITC-conjugated mouse anti -rat CD161 (3.2.3), purifi ed mouse anti -rat CD68 (ED2; Serotec Ltd), or rabbit anti -rat C9 (provided by B.P. Morgan, University of Cardiff , Cardiff , strengthens our conclusions over those made by Szaba and Smiley ( 14 ) .
Our data also show the importance of thrombin and PAR-1 for the generation of MCP-3 and MCP-5, two other ligands of CCR2. We have not addressed the precise role of these chemokines relative to MCP-1 in our models, nor the interplay between them, particularly between MCP-1 and MCP-3. However, our observations are consistent with those of Inouye et al. ( 8 ) , who, on fi nding signifi cantly reduced MCP-3 levels in MCP-1 KO mice, suggested that MCP-3 might be regulated by MCP-1.
Previous work has shown that thrombin can promote the release of preformed MCP-1 from intracellular vesicles ( 15 ) and induce MCP-1 synthesis from various cells ( 16, 17 ) , either directly through PAR-mediated signaling or indirectly via release of infl ammatory cytokines from bystander leukocytes ( 18, 19 ) . Our work complements and extends all these previous data by showing the critical role that thrombin plays in promoting MCP-1 generation in vivo.
The fact that PAR-4 signaling played no role in our models may be partially explained by well-defi ned diff erences in the avidity of thrombin for PAR-1 compared with PAR-4 ( 20 ) . However, our results also show that maximal activation of PAR-4 on microvascular ECs was incapable of stimulating signifi cant MCP-1 production ( Fig. 2 c ) . In contrast, in vivo production of MCP-5 appeared equally reliant on PAR-1 and PAR-4.
This work is the fi rst to demonstrate that thrombin is necessary in vivo to promote NK cell and M ⌽ recruitment through locally generated tissue chemokines. Although from the data presented here we cannot rule out an indirect role for thrombin through, for instance a thrombin-dependent PAR-1 activator such as activated protein C, it is likely that thrombin is acting directly on PAR-1, as the importance of PAR-1 signaling by activated protein C at physiological concentrations is under debate. That thrombin should be so important in the heart transplant model is surprising, as the humoral immune response against both WT and Tg hearts is intact ( 5, 6 ) , with signifi cant deposits of IgM, IgG (of all isotypes), C3, and C9 on the ECs of rejecting grafts. Many of these factors, but especially C components, have been shown in other model systems to induce MCP-1 generation ( 21 ) or have direct chemotactic activity for M ⌽ s ( 22 ) , as have IFN-␥ , TNF-␣ , and IL-6 ( 16, 23 -25 ) . However, our data indicates that each of these was unable to promote signifi cant donor MCP-1 production in the absence of PAR-1.
Interestingly, systemic administration of PAR Ags did not lead to massively elevated levels of these rat cytokines, despite the theoretical potential for PAR to be activated on all circulating cells. The most likely explanation is that a second signal, generated by contact with the xenogeneic heart, for instance, is required for cellular activation. Consistent with this, in vitro cultures using rat NK cells revealed that PAR-1 Ags were incapable of stimulating IFN-␥ secretion unless mouse ECs were present, in which case PAR-1 activation signifi cantly enhanced IFN-␥ production (not depicted).
